Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 42 studies | 53% ± 26% | |
fibroblast | 24 studies | 51% ± 25% | |
pericyte | 24 studies | 46% ± 27% | |
smooth muscle cell | 18 studies | 48% ± 25% | |
astrocyte | 17 studies | 54% ± 22% | |
oligodendrocyte precursor cell | 15 studies | 73% ± 19% | |
capillary endothelial cell | 14 studies | 34% ± 20% | |
glutamatergic neuron | 13 studies | 64% ± 21% | |
endothelial cell of artery | 13 studies | 40% ± 23% | |
GABAergic neuron | 11 studies | 63% ± 25% | |
adipocyte | 11 studies | 79% ± 21% | |
microglial cell | 8 studies | 43% ± 27% | |
vein endothelial cell | 8 studies | 45% ± 24% | |
neuron | 7 studies | 46% ± 27% | |
interneuron | 7 studies | 61% ± 25% | |
retina horizontal cell | 6 studies | 66% ± 23% | |
myofibroblast cell | 6 studies | 39% ± 26% | |
cardiac muscle cell | 6 studies | 68% ± 21% | |
mesothelial cell | 6 studies | 59% ± 28% | |
epithelial cell | 6 studies | 44% ± 26% | |
type II pneumocyte | 6 studies | 70% ± 20% | |
retinal bipolar neuron | 5 studies | 49% ± 29% | |
amacrine cell | 5 studies | 41% ± 19% | |
endothelial cell of vascular tree | 5 studies | 55% ± 25% | |
endothelial cell of lymphatic vessel | 5 studies | 33% ± 13% | |
basal cell | 5 studies | 37% ± 16% | |
club cell | 5 studies | 41% ± 15% | |
type I pneumocyte | 5 studies | 29% ± 5% | |
cholangiocyte | 4 studies | 59% ± 15% | |
hepatocyte | 4 studies | 64% ± 22% | |
granule cell | 4 studies | 56% ± 9% | |
macrophage | 4 studies | 30% ± 16% | |
retinal pigment epithelial cell | 4 studies | 64% ± 29% | |
Mueller cell | 4 studies | 32% ± 19% | |
ON-bipolar cell | 4 studies | 63% ± 23% | |
retinal ganglion cell | 4 studies | 54% ± 17% | |
connective tissue cell | 4 studies | 43% ± 22% | |
oligodendrocyte | 4 studies | 32% ± 22% | |
endothelial cell of sinusoid | 3 studies | 39% ± 16% | |
hepatic stellate cell | 3 studies | 70% ± 13% | |
glomerular endothelial cell | 3 studies | 45% ± 2% | |
abnormal cell | 3 studies | 40% ± 23% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 52% ± 4% | |
GABAergic interneuron | 3 studies | 58% ± 27% | |
progenitor cell | 3 studies | 43% ± 12% | |
endocardial cell | 3 studies | 64% ± 27% | |
ciliated cell | 3 studies | 18% ± 1% | |
GABAergic amacrine cell | 3 studies | 72% ± 12% | |
OFF-bipolar cell | 3 studies | 43% ± 18% | |
glycinergic amacrine cell | 3 studies | 43% ± 8% | |
rod bipolar cell | 3 studies | 76% ± 30% | |
ependymal cell | 3 studies | 70% ± 5% | |
muscle cell | 3 studies | 39% ± 7% | |
mast cell | 3 studies | 30% ± 19% | |
mucus secreting cell | 3 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 2272.82 | 2591 / 2642 | 100% | 17.56 | 702 / 705 |
kidney | 100% | 3229.67 | 89 / 89 | 97% | 21.63 | 876 / 901 |
intestine | 100% | 3291.29 | 962 / 966 | 96% | 9.40 | 505 / 527 |
breast | 100% | 6053.76 | 458 / 459 | 93% | 11.00 | 1036 / 1118 |
thymus | 100% | 6453.99 | 652 / 653 | 93% | 22.55 | 560 / 605 |
ovary | 100% | 4788.24 | 180 / 180 | 92% | 11.30 | 397 / 430 |
prostate | 98% | 3056.95 | 241 / 245 | 93% | 7.79 | 465 / 502 |
adrenal gland | 100% | 4996.53 | 258 / 258 | 88% | 9.93 | 203 / 230 |
lung | 100% | 6109.43 | 578 / 578 | 87% | 8.60 | 1005 / 1155 |
stomach | 84% | 2165.41 | 303 / 359 | 96% | 11.28 | 275 / 286 |
esophagus | 85% | 2435.02 | 1225 / 1445 | 93% | 10.96 | 170 / 183 |
skin | 84% | 3171.00 | 1522 / 1809 | 88% | 17.77 | 417 / 472 |
bladder | 100% | 3254.48 | 21 / 21 | 71% | 6.10 | 358 / 504 |
uterus | 99% | 4285.22 | 169 / 170 | 65% | 7.18 | 299 / 459 |
pancreas | 57% | 775.90 | 187 / 328 | 94% | 9.47 | 168 / 178 |
liver | 58% | 833.90 | 132 / 226 | 77% | 6.83 | 314 / 406 |
adipose | 100% | 7559.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8828.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2751.96 | 848 / 861 | 0% | 0 | 0 / 0 |
spleen | 90% | 1968.36 | 218 / 241 | 0% | 0 | 0 / 0 |
muscle | 89% | 1932.24 | 714 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 53% | 3.19 | 42 / 80 |
tonsil | 0% | 0 | 0 / 0 | 49% | 3.42 | 22 / 45 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.35 | 7 / 29 |
peripheral blood | 1% | 24.11 | 11 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010633 | Biological process | negative regulation of epithelial cell migration |
GO_1903385 | Biological process | regulation of homophilic cell adhesion |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005001 | Molecular function | transmembrane receptor protein tyrosine phosphatase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPRG |
Protein name | PTPRG protein Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48) Protein tyrosine phosphatase gamma Alternative protein PTPRG |
Synonyms | PTPG |
Description | FUNCTION: Possesses tyrosine phosphatase activity. . |
Accessions | P23470 Q86TJ8 O60420 Q49A02 ENST00000474889.6 [P23470-1] L8E7E6 ENST00000295874.14 [P23470-2] |